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 
Abstract— Ozone autohemotherapy is an emerging 
therapeutic technique that is gaining increasing importance in 
treating neurological disorders. A validated and standard 
methodology to assess the effect of such therapy on brain 
metabolism and circulation is however still lacking. We used a 
near-infrared spectroscopy system (NIRS) to monitor the 
cerebral oxygenation of 9 subjects: 4 remitting-relapsing 
multiple sclerosis (MS) sufferers and 5 controls. Subjects were 
tested before, during, and after ozone autohemotherapy. We 
monitored the concentration changes in the level of oxygenated 
and deoxygenated haemoglobin, and in the level of the 
Cytochrome-c-oxidase (CYT-c). From the time and time-
frequency analysis of the NIRS signals we extracted 128 
variables, which were used to characterize the metabolic brain 
pattern during the therapy. We showed that by using only 7 
NIRS variables out of 128 it is possible to characterize the 
metabolic brain pattern of the two groups of subjects. The MS 
subjects showed a marked increase of the CYT-c activity and 
concentration about 40 minutes after the end of the 
autohemotherapy, possibly revealing a reduction of the chronic 
oxidative stress level typical of MS sufferers. From a technical 
point of view, this preliminary study showed that NIRS could 
be useful to show the effects of ozone autohemotherapy at 
cerebral level, in a long term monitoring. The clinical result of 
this study is the quantitative measurement of the CYT-c level 
changes in MS induced by ozone autohemotherapy. 
Keywords—ozone autohemotherapy, near-infrared 
spectroscopy, cerebrovascular reactivity, time-frequency 
analysis. 
I. INTRODUCTION 
Recent studies showed that ozone autohemotheraphy 
could be very useful to treat vascular diseases [1], wounds 
[2], and to prevent limb ischemia in dialysed subjects [3]. 
The above referenced studies demonstrated the ozone 
capabilities of boosting the overall metabolism and, 
particularly, of enhancing peripheral tissue oxygenation. 
Particular attention has been given to the possibility of 
utilizing ozone in neurology, in order to enhance brain 
oxygenation [1]. Reduced oxygen supply to brain tissues and 
cerebral chronic venous insufficiency have, in fact, been 
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related to different neurodegenerative disorders [4]. Besides 
increasing the oxygenation level of the tissues, ozone is 
known to induce an increase in the metabolic rate and to 
lower the overall inflammation state [5]. This anti-
inflammatory effect could be particularly useful in treating 
autoimmune chronic pathologies, such as multiple sclerosis 
(MS). 
Previous studies tried to quantify the effect of ozone 
autohemotherpy by considering mainly biochemical 
reactions [5] and vascular changes [3], but an in-vivo 
uniformed and standardized evaluation protocol of such 
effects on brain tissue is still missing.  
Near-infrared spectroscopy (NIRS) is a non-invasive 
technique to monitor the changes in the brain concentrations 
of oxygenated (O2Hb) and reduced (HHb) haemoglobin in 
real-time. Additionally, NIRS can measure changes in 
Cytochrome-c-oxidase (CYT-c) concentration, an enzyme 
involved in the chain of cellular respiration and therefore 
representative of cellular energy consumption, particularly at 
mitochondrial level.  
In this study, we used NIRS to monitor the long-term 
effects of ozone autohemotherapy in neurological subjects. 
The overall duration of the monitoring was about 2.5 hours. 
We wanted to focus on the long-term effect to avoid the 
obvious increase of blood oxygen saturation that is caused by 
ozone autohemotherapy. We studied patients affected by 
Multiple Sclerosis (MS) and controls. Since the spectral 
content of the NIRS signals contains information about 
cerebral vasomotor reactivity, we studied the signals in the 
time-frequency domain. Traditional time analysis was carried 
out as well. PCA, two way ANOVA and MANOVA were 
used to study the differences of the ozone authoemotherapy 
effects between patients and controls, and particularly to 
show the effects on brain metabolism of ozone. To the very 
best of our knowledge, this study is the first one investigating 
the long-term effect of ozone therapy in neurological 
patients. 
II. METHODS 
A. Experimental setup 
The ozone therapy protocol started with the drawning of 
240 grams of blood from the subjects’ antecubital vein. The 
blood was then mixed with 180 ml of O2/O3, composed by 
O2 at 50%, with an O3 concentration equal to 40 μg/ml 
(M95, Multioxygen, Gorle (BG), Italy). The ozonized blood 
was then slowly reinjected.  
Hence, the overall protocol consisted of a) baseline 
initial recording (average duration 258±58 s), b) blood 
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drawing and ozonization (326±154 s), c) reinjection 
(1520±804 s), d) post-injection monitoring (1.5 hours). 
The NIRS recordings were made using a commercially 
available oximeter (NIRO300, Hamamatsu Photonics K.K., 
Japan) and the sampling rate was set to 2 Hz. The NIRS 
probe, consisting of a photo-detector and four infrared LED 
sources (wavelengths equal to 775, 810, 830 and 910 nm) 
was placed on the subject’s forehead 2 cm away from 
midline and 1 cm above the supraorbital ridge. During all the 
test, the subjects were asked to rest in supine position, in a 
quiet room and with eyes closed.  
 
After having been instructed about the overall procedures 
and having signed a written informed consent, 9 subjects (5 
controls and 4 MS sufferers) underwent ozone therapy. We 
enrolled in the study patients suffering from relapsing-
remitting MS. Table I summarizes the patients’ 
demographics. 
B. NIRS signal processing 
NIRS monitoring was carried out during the entire 
therapy protocol and lasted for about 1.5 hours after blood 
reinjection. We investigated the acquired signals in 8 
different time intervals, lasting 256 s each. These 8 analysis 
windows were centred on I) baseline recording, II) blood 
drawing, III) middle of reinjection period, IV) end (last 256 
s) of reinjection, V) 20 minutes after reinjection, VI) 40 
minutes after reinjection, VII) 1 hour after reinjection and 
VIII) 1.5 hours after the reinjection. We selected these 
windows because we wanted to monitor each specific phase 
of the ozone autohemotherapy. For each window, on each 
patient we performed a time domain analysis and a time-
frequency domain (TF) analysis. In fact, it was already 
shown that NIRS cerebral signals are characterized by a 
marked nonstationarity [5]. We analyzed the following 4 
signals: O2Hb, HHb, CYT-c, and Tissue Oxygen Index 
(TOI). The TOI is defined as the ratio between O2Hb and the 
total haemoglobin (i.e. O2Hb + HHb). 
The time analysis was made by averaging the signal 
amplitude in each of the observation windows, in order to 
analyze the changes in the haemoglobin concentrations in 
the brain tissue. Therefore, thirty-two variables were 
generated by time domain analysis (i.e. four signals in eight 
observation epochs). 
The time-frequency analysis was made by means of the 
Choi-Williams distribution (CW) of the Cohen’s class (with 
σ = 0.5). From the CWs, we measured the signals’ power in 
two frequency bands: very low frequency (VLF: 20mHz - 
60mHz) and low frequency (LF: 60mHz - 140mHz). Also, 
we measured the total signal power (PTOT) for the 4 signals. 
Fig.1 shows the CYT-c signal during the VI observation 
window in both time and time-frequency domains. The VLF 
band is related to the long-term vasomotor reactivity, 
whereas the LF band is correlated to the activity of the 
sympathetic system and, hence, to the cerebral 
autoregulation [6]. We then computed the relative 
percentage powers PVLF/ PTOT and PLF/ PTOT for the O2Hb, 
HHb, CYT-c and TOI concentrations, in the 8 analysis 
windows and for all the sample population. Thus, we 
computed 96 variables using the time-frequency analysis. 
Considering the 32 variables computed from the time 
domain analysis, the total number of variables was 128. 
C. Variable reduction and supervised/unsupervised analysis 
The aim of our analysis was to find the most important 
variables characterizing the NIRS pattern of controls and 
MS subjects during the entire experiment. Therefore, as first 
TABLE I.  SUBJECTS DEMOGRAPHICS 
 Controls MS subjects 
Number of subjects (# 
females) 
5 (4) 4 (1) 
Age (years) 68.2 ± 3.3 38.0 ± 3.4 
BMI (kg/m2) 25.57 ± 2.71 24.23 ± 3.49 
 
 
 a)                                                                                                                    b) 
Figure 1.  The CYT-c signal is showed in the time and time-frequency domain during the observation window number VI. a) is referred to a control 
subject while b) has been obtained from an MS sufferer. VLF and LF frequency bands have been superimposed for easiness of reading. The TF analysis 
highlights a pronounced difference between the two subjects. 
  
step, we removed the collinear variables. The number of 
variables was reduced by means of a balanced one-way 
ANOVA between each of the dependent variables and the 
subject’s pathology (considered as independent variable). 
We considered significant those variables that reported a p-
value equal or smaller than 0.01. The following part of the 
work has been carried on the remaining 17 variables as 
reported by Table II.  
In order to discover any difference in the therapy 
response of the two groups, we applied a Principal 
Component Analysis (PCA) to the normalized variable set. 
Fig. 2 shows how the first two PCs (accounting for almost 
the 80% of the total variance) can easily differentiate the 
response of MS patients from the controls’ one. The five 
higher loadings for PC1 were assigned to the Mean O2Hb in 
windows VI, IV, V, to the Mean CYT-c III and to the PTOT 
CYT-c VI. We completed our analysis investigating the 
source of variance in the data set by means of a two way 
ANOVA. We focused the ANOVA on both the variance 
generated by the different patients and the variance 
generated by the different observation windows. The p-
values obtained were smaller than 0.01 and therefore we 
rejected the three different null hypothesis (i.e. all patients 
belong to the same population, all the observation windows 
belong to the same population and there is no relation 
between patient group and window).   
To discriminate those variables responsible for the 
biggest part of the total variance we performed a Wilks’ 
lambda test on the reduced variables set as in equation (1): 
     
  
      
 
Here |W| is the determinant of the within group variance 
matrix, while |B| is the determinant of the between groups 
variance matrix. As a consequence the variables with the 
smaller   have been chosen as the more suitable for subjects 
classification in the two different groups. 
In order to group the subjects using a single parameter we 
performed a linear combination of the available variables by 
means of a MANOVA. To avoid singularity problems when 
working with variance and covariance matrices, we used the 
first 7 variables showing the smaller   (Table III). 
This analysis reported that the dimension of the space 
containing the group means is equal to one, i.e. it was 
possible to differentiate the subjects with a single canonical 
variable as showed in Fig. 3. 
III. RESULTS AND DISCUSSION 
We used NIRS long-term monitoring to detect possible 
differences in the cerebrovascular metabolic pattern of MS 
sufferers compared to healthy volunteers. We coupled a time 
analysis to time-frequency analysis to investigate both the 
volumetric and metabolic effect of the ozone 
 
Figure 2.  PCA, the figure represents the patients in the space of the 
first two PCs. The subjects can be divided in two groups accounting on 
the value of the first PC. 
 
TABLE II.  VARIABLES AFTER ANOVA 
TIME  DOMAIN 
 VARIABLE OBSERVATION WINDOWS 
 Mean O2Hb II 
Mean CYT-c II, VIII 
 TIME-FREQUENCY DOMAIN 
 PVLF CYT-c I, VI 
PLF CYT-c VI 
PTOT CYT-c VI 
 
 
Figure 3.  MANOVA,  the figure represents the subjects in the space 
of the first two canonical variables. The subjects can be divided in two 
groups accounting on the value of CV 1. 
TABLE III.  VARIABLES AFTER ANOVA 
TIME  DOMAIN 
 VARIABLE OBSERVATION WINDOWS 
 Mean O2Hb II, IV, V, VI, VII, VIII 
Mean CYT-c II, III, VI, VII, VIII 
 TIME-FREQUENCY DOMAIN 
 PVLF CYT-c I, VI 
PLF CYT-c I, VI 
PTOT CYT-c I, VI 
 
  
autohemotherapy (time domain) and its effect on the cerebral 
vasomotor reactivity (frequency domain). Time-frequency 
analysis was needed to cope with the overt signals’ 
nonstationary nature. Of the 7 variables that resulted as 
discriminant, three were computed in the time domain and 
four in the time-frequency domain (Table III).  
Our results showed that by using 7 variables computed on 
the NIRS signals, it is possible to differentiate the metabolic 
pattern of the two groups. The three discriminant variables 
computed in the time domain were the O2Hb and CYT-c 
concentrations during blood drawing (phase II of the 
protocol) and the CYT-c concentration at the end of the 
monitoring (phase VIII), after 1.5 hours from blood 
reinfusion. The remaining four discriminant variables were 
all computed in the time-frequency domain and were all 
relative to the CYT-c signal. Three of these were the power 
of the CYT-c signal in the VLF and LF bands, and the total 
power of the signal recorded during phase VI of the protocol, 
which was 40 minutes after reinjection. All variables were 
statistically different between the two groups (Student’s t-
test, p < 0.05). Table IV summarizes the mean values of the 
variables in the two groups. 
Our results demonstrate that the ozone autohemotherapy 
has a clear effect in triggering the CYT-c signal, particularly 
in MS patients. The CYT-c levels in MS are lower than in 
controls due to mitochondrial damage that is characteristic of 
the MS disease and our in-vivo data confirm this finding [7]. 
A previous study hypothesized the presence of oxidative 
damage to DNA in association with inflammation in chronic 
active plaques, which are the typical white matter damages 
associated to MS [8]. The same study showed how the 
oxidative damage developed in association with 
inflammation in the central nervous system, and might 
contribute to a decline of energy metabolism in affected cells. 
Consequently, there could be impairment in the CYT-c 
production in MS patients due to inflammation induced 
oxidative stress. In a recent study, Sagai et al. showed that 
ozone induced a mild oxidative stress [5]. Such mild action 
triggered the production of free antioxidants and anti-
oxidative enzymes, which not only protected cells from 
oxidation and inflammation, but also reversed the chronic 
oxidative stress. Our findings about the increased activity 
(higher power in time-frequency representations of the CYT-
c signal) seem to confirm that ozone promotes the reduction 
of chronic oxidative stress and, consequently, enhances the 
mitochondrial functionality of neural cells. This effect is 
particularly visible on the MS patients because of their 
starting conditions of hyper-oxidative stress and lower CYT-
c levels. 
We coupled unsupervised (PCA) and supervised 
(MANOVA) analysis strategies in order to better understand 
if the independent and non-collinear variables were actually 
descriptive of our sample population. The two approaches 
gave substantially the same result in terms of subjects’ 
clustering, therefore indicating that the selected variables 
were discriminant between the two groups. Therefore, we 
believe that the NIRS technique could be suitable for the 
long-term monitoring of the effects on brain metabolism and 
vasomotor reactivity induced by ozone therapy.  
In conclusion, we propose the joint approach of NIRS 
recordings, time and time-frequency analysis, and 
supervised/unsupervised clustering techniques as suitable in 
physiological and neuroscience experimental protocols 
[9,10]. 
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TABLE IV.  MEAN VALUES OF THE 7 DISCRIMINANT VARIABLES. 
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THE TWO GROUPS (STUDENT’S T-TEST, P < 0.05). 
VARIABLE 
Mean ± σ 
CONTROLS 
Mean  ± σ 
MS 
   Mean O2Hb II -0.66 ± 0.51 1.99 ± 1.22 
Mean CYT-c II 0.08 ± 0.05 -0.19 ± 0.12 
Mean CYT-c VIII 0.00 ± 0.20 -0.41 ± 0.13 
PVLF CYT-c I 0.02 ± 0.00 0.05 ± 0.01 
PVLF CYT-c VI 0.02 ± 0.00 0.05 ± 0.01 
PLF CYT-c VI 0.06 ± 0.00 0.11 ± 0.02 
PTOT CYT-c VI 0.14 ± 0.01 0.23 ± 0.04 
 
